Navigation Links
BioDrain Medical Inc. Appoints New Board Member

MINNEAPOLIS, March 14, 2012 /PRNewswire/ -- BioDrain Medical, Inc. (OTCBB: BIOR, OTCQB: BIOR), producer of the FDA cleared STREAMWAY System for automated surgical fluid disposal, announced today that it has appointed Joshua Kornberg to the Company's Board of Directors.

Kevin Davidson, Chief Executive Officer of BioDrain, commented, "We are thrilled to bring Josh onboard. As cofounder of Atlantic Partners Alliance, a healthcare and biotechnology fund dedicated to bridge financing of companies in search of short-term capital, Josh brings to our Board an excellent understanding of how to help an early stage company progress. We are confident that his consulting expertise in regards to sales, marketing, and strategic development, as well as in technical strategies such as regulatory adherence, clinical staging and product evaluation, will be extremely valuable in building out our operations and increasing awareness in the medical device community of the benefits of our unique STREAMWAY System."

Mr. Kornberg is also President and founding partner of GPF, a private equity fund based in New York. Prior to founding GPF, Mr. Kornberg served as Chief Investment Officer of The Lightstone Group, a national private equity firm, and Director of the Lightstone Value Plus REIT, a public company focused on commercial real estate. Additionally, Mr. Kornberg served as Director of Acquisitions and Development at ARK Realty Investors, a real estate investment and development firm. He also worked in the capital markets group at Morgan Stanley and served as Vice President at The RREEF Funds, a leading global pension fund advisor.

About BioDrain Medical, Inc.

BioDrain Medical, Inc. has a fully automated, patented and FDA cleared surgical fluid disposal system that virtually eliminates operating room workers' exposure to blood, irrigation fluid and other potentially infectious fluids found in the surgical environment. Current manual surgical fluid handling methods of hand-carrying filled surgical fluid canisters and emptying these canisters is an exposure risk and an antiquated approach to the handling of surgical fluid waste. BioDrain's STREAMWAY System however fully automates the collection, measurement and disposal of surgical fluids, resulting in: 1) reducing overhead costs to hospitals and surgical centers, 2) improving the Occupational State and Health Association (OSHA) and other regulatory compliance, and 3) improving the efficiency of the operating room (and thereby making surgeries more profitable).

BioDrain's STREAMWAY System presents a sustainable solution to fluid disposal in operating rooms. Presently, around 50 million bloody, potentially disease infected canisters go to landfills in the United States annually. Moreover, these tainted canisters can remain in landfills for years. With the installation of BioDrain's STREAMWAY System, the number of these canisters can be significantly reduced, making both the operating room and our environment safer and cleaner. Independent professional sales representatives that cater to the needs of hospitals and ambulatory surgical centers across the country are currently representing BioDrain products. For additional information, please visit:

Forward-looking Statements:

Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the company's business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the company's ability to implement its long range business plan for various applications of its technology; the company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the company's reports filed with the Securities and Exchange Commission. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the company's financial position. See the company's most recent Quarterly Report on Form 10-Q and related 8-K filings.

Investor Relations Contact:

Mr. Kevin Fickle, President
Tel: +1-925-330-8315


Stanley Wunderlich
Consulting for Strategic Growth 1 Ltd.
Tel: 800-625-2236 ext. 7770


SOURCE BioDrain Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BioDrain Streamway® System Receives Positive Evaluations on Two Additional Units
2. BioDrain Medical, Inc. Reports Results of Annual Meeting
3. BioDrain Medical, Inc. Retains EKN Financial Services as Its Exclusive Financial Advisor and Placement Agent
4. BioDrain Medical, Inc. Completes Installation of Its Streamway™ Automated Surgical Fluid Disposal System in Minnesota Hospital
5. BioDrain Medical, Inc. Retains CFSG1 as Its U.S. Investor Relations Firm
6. BioDrain Medical, Inc. Is Eligible for Trading on the OTCBB, Notice of Allowance on Canadian Patent Application
7. American Capital and its Affiliates Invest $20 Million in Portfolio Company Halt Medical
8. Solta Medical Provides Update on Liposonix Launch
9. Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound Markets
10. UMF Medical Announces New Name
11. Benchmark Mobility Inc. Annouces Sell of Home Medical Businesses
Post Your Comments:
(Date:11/27/2015)... 27, 2015 --> ... go online. The potential to save costs, improve treatment ... far from fully exploited as yet. Here, particular emphasis ... either via mobile tablet or directly at the patients, ... ) -->      (Photo: ...
(Date:11/27/2015)... , Nov. 26, 2015 ... addition of the "2016 Global Tumor ... Country Volume and Sales Segment Forecasts, Innovative ... report to their offering. --> ... of the "2016 Global Tumor Marker ...
(Date:11/26/2015)... 2015 --> ... blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... that immunotherapy can be efficiently combined with photodynamic therapy ...
Breaking Medicine Technology:
(Date:11/27/2015)... , ... November 27, 2015 , ... CBD College ... of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. ... accredited colleges, as only one of twelve colleges and universities in the state of ...
(Date:11/27/2015)... ... , ... Avid collector, Andrew Hawley from Vintage Rock Posters, announces his search ... one of Joplin's most famous and beautiful concert posters. The concert was held on ... Arbor. The According to Hawley, "It is hard to believe that Joplin's stardom was ...
(Date:11/26/2015)... Las Vegas, NV (PRWEB) , ... November 26, 2015 , ... ... holiday shopping strategy. Many customers choose to buy during the Black Friday and ... holiday gifts. Shoppers don’t need to search the Internet high and low to find ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied Drug Delivery ... to integrate dose form selection in early phase drug development. The first of ... and bringing together the UK’s emerging life sciences companies, corporate partners, and investors, ...
(Date:11/26/2015)... ... 26, 2015 , ... WorldCare International, Inc., the first company ... Employee Benefits Conference. The Employee Benefits Conference was hosted by the International Foundation ... 11th, 2015. The conference was held at the Hawaii Convention Center in Honolulu, ...
Breaking Medicine News(10 mins):